This Specialized Heart Monitor Draws Health Fund Attention
A major healthcare-focused fund just nudged its bets into a wearable heart-monitor company. This move spotlights the ...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesA major healthcare-focused fund just nudged its bets into a wearable heart-monitor company. This move spotlights the ...
As energy demand grows, NuScale Power offers a potential long-term angle with small modular reactors. This guide expl...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
Two-thirds of the S&P 500 have reported, and the results are surprisingly strong. This could mean smoother gains for ...
Crypto traders are weighing ripple (xrp) solana (sol) as summer enters. The rivals push higher, but investors cite di...
As Oklo enters 2026, the Q1 earnings landscape offers clues about its path to commercialization. This guide breaks do...
Rocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
The chef’s colicchio return tech story highlights how nontraditional investors are finding outsized gains in niche te...
Investors are watching Lilly stock: next stop as the company leverages obesity and diabetes drugs, while facing risin...
As of March 31, 2026, NVIDIA, Apple, and Microsoft account for roughly 43% of VGT, raising questions about true diver...
A hedge fund's large bet on MercadoLibre has investors buzzing. This guide explains what the move might mean for MELI...
An activist investor’s purchase often signals interest in a company’s next chapter. Read how Edward Garden’s stake co...